Haemophilus influenzae b vaccine
Term · Oncology and biomedicine · MLC-T-ONC-014055
A vaccine against serotype b of the Gram-negative bacterium H. influenzae (Hib). Hib vaccines contain polysaccharide-protein conjugate antigens that produce greater host immune responses than first-generation purified polysaccharide vaccine. These vaccines may differ with regard to use of protein carriers, polysaccharides, diluents, and preservatives.
| Identifier | MLC-T-ONC-014055 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Haemophilus b conjugate vaccine; Haemophilus b oligosaccharide conjugate vacccine; Haemophilus influenzae B Polysaccharide Conjugate Vaccine (PRP-OMP); Haemophilus influenzae B Polysaccharide Conjugate Vaccine (PRP-T); Hib TITER vaccine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014055",
"term": "Haemophilus influenzae b vaccine",
"field": "Oncology and biomedicine",
"definition": "A vaccine against serotype b of the Gram-negative bacterium H. influenzae (Hib). Hib vaccines contain polysaccharide-protein conjugate antigens that produce greater host immune responses than first-generation purified polysaccharide vaccine. These vaccines may differ with regard to use of protein carriers, polysaccharides, diluents, and preservatives.",
"synonyms": [
"Haemophilus b conjugate vaccine",
"Haemophilus b oligosaccharide conjugate vacccine",
"Haemophilus influenzae B Polysaccharide Conjugate Vaccine (PRP-OMP)",
"Haemophilus influenzae B Polysaccharide Conjugate Vaccine (PRP-T)",
"Hib TITER vaccine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/haemophilus-influenzae-b-vaccine/"
}
Record 8,255 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.